1,051
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Maternal and fetal outcomes of intraplacental choriocarcinoma complicated by fetomaternal hemorrhage: a systematic review

A risk in pregnancy that is difficult to diagnose

, , , , , , & show all
Article: 2285238 | Received 01 Aug 2023, Accepted 14 Nov 2023, Published online: 27 Nov 2023

References

  • Shih I. Gestational trophoblastic neoplasia – pathogenesis and potential therapeutic targets. Lancet Oncol. 2007;8(7):642–650. doi: 10.1016/S1470-2045(07)70204-8.
  • Schmid P, Nagai Y, Agarwal R, et al. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet. 2009;374(9683):48–55. doi: 10.1016/S0140-6736(09)60618-8.
  • Sala A, Ornaghi S, Delle Marchette M, et al. Gestational intraplacental choriocarcinoma in a term pregnancy: a case report. Cureus. 2022;14(11):e31243. doi: 10.7759/cureus.31243.
  • Ryu N, Ogawa M, Matsui H, et al. The clinical characteristics and early detection of postpartum choriocarcinoma. Int J Gynecol Cancer. 2015;25(5):926–930. doi: 10.1097/IGC.0000000000000184.
  • Seckl MJ, Sebire NJ, Fisher RA, et al. Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl. 6):vi39–vi50. doi: 10.1093/annonc/mdt345.
  • Azizi M, Akbarzade-Jahromi M, Ghaffari P, et al. Delayed diagnosis of intraplacental choriocarcinoma in a term healthy neonate—a case report and literature review. Clin Case Rep. 2022;10(11):e6640.
  • Benson PF, Goldsmith KL, Rankin GL. Massive foetal haemorrhage into maternal circulation as a complication of choriocarcinoma. Br Med J. 1962;1(5281):841–842. doi: 10.1136/bmj.1.5281.841.
  • Aso K, Tsukimori K, Yumoto Y, et al. Prenatal findings in a case of massive fetomaternal hemorrhage associated with intraplacental choriocarcinoma. Fetal Diagn Ther. 2009;25(1):158–162. doi: 10.1159/000209201.
  • Jacques SM, Qureshi F, Doss BJ, et al. Intraplacental choriocarcinoma associated with viable pregnancy: pathologic features and implications for the mother and infant. Pediatr Dev Pathol. 1998;1(5):380–387. doi: 10.1007/s100249900052.
  • Datta T, Banerjee A, Adeyemo A, et al. Intraplacental choriocarcinoma associated with pregnancy continuum: a diagnostic dilemma. J Obstet Gynaecol. 2007;27(7):731–732. doi: 10.1080/01443610701691965.
  • She Q, Cheng Z, El-Chaar D, et al. Intraplacental choriocarcinoma coexisting with fetomaternal hemorrhage: case report, chemotherapy management, and literature review. Medicine. 2018;97(14):e9977. doi: 10.1097/MD.0000000000009977.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.
  • PROSPERO international prospective register of systematic reviews; 2023 [cited 2023 Jan 10].
  • Simões M, Vale G, Lacerda C, et al. Fetomaternal hemorrhage: a clue to intraplacental choriocarcinoma and neonatal malignancy. J Matern Fetal Neonatal Med. 2022;35(25):6615–6617.
  • Jeong JE, Moon SH, Park KE, et al. Fetomaternal hemorrhage caused by an intraplacental choriocarcinoma. Korean J Obstet Gynecol. 2012;55(1):33–37. doi: 10.5468/KJOG.2012.55.1.33.
  • Touboul C, Faivre E, Boithias C, et al. Hémorragie foetomaternelle sur choriocarcinome placentaire [Fetomaternal hemorrhage caused by intraplacental choriocarcinoma]. J Gynecol Obstet Biol Reprod. 2010;39(2):156–158. doi: 10.1016/j.jgyn.2009.10.008.
  • Takahashi H, Matsuda H, Mizumoto Y, et al. Intraplacental choriocarcinoma with fetomaternal hemorrhage: a case study and literature review. J Perinat Med. 2008;36(2):178–181.
  • Hookins B, Vatsayan A. Intraplacental choriocarcinoma and fetomaternal haemorrhage and maternal disseminated intravascular coagulopathy in a term pregnancy: a case report. Case Rep Womens Health. 2020;27:e00216. doi: 10.1016/j.crwh.2020.e00216.
  • Koike Y, Wakamatsu H, Kuroki Y, et al. Fetomaternal hemorrhage caused by intraplacental choriocarcinoma: a case report and review of literature in Japan. Am J Perinatol. 2006;23(1):49–52. doi: 10.1055/s-2005-918893.
  • Lam CM, Wong SF, Lee KW, et al. Massive feto-maternal hemorrhage: an early presentation of women with gestational choriocarcinoma. Acta Obstet Gynecol Scand. 2002;81(6):573–576. doi: 10.1034/j.1600-0412.2002.810620.x.
  • Henningsen AK, Maroun LL, Havsteen H, et al. Massive fetomaternal hemorrhage caused by an intraplacental choriocarcinoma: a case report. Case Rep Med. 2010;2010:767218. doi: 10.1155/2010/767218.
  • Peng HH, Ng ZP, Tang YH, et al. Term pregnancy with choriocarcinoma presenting as severe fetal anemia and postpartum hemorrhage. Taiwan J Obstet Gynecol. 2016;55(3):430–433. doi: 10.1016/j.tjog.2016.04.021.
  • Takai N, Miyazaki T, Yoshimatsu J, et al. Intraplacental choriocarcinoma with fetomaternal transfusion. Pathol Int. 2000;50(3):258–261. doi: 10.1046/j.1440-1827.2000.01036.x.
  • Jiao L, Ghorani E, Sebire NJ, et al. Intraplacental choriocarcinoma: systematic review and management guidance. Gynecol Oncol. 2016;141(3):624–631. doi: 10.1016/j.ygyno.2016.03.026.
  • Chou HC, Chen RL, Yau KI, et al. Infantile choriocarcinoma with idiopathic massive fetomaternal hemorrhage. Med Pediatr Oncol. 2002;38(3):203–204. doi: 10.1002/mpo.1311.
  • Nagel HT, Vandenbussche FP, Smit VT, et al. Intraplacental choriocarcinoma as an unexpected cause of intrauterine death at term. Int J Gynecol Cancer. 2007;17(6):1337–1339. doi: 10.1111/j.1525-1438.2007.00987.x.
  • Schepisi C, Dunsmuir P, Lipsett J, et al. Intraplacental choriocarcinoma in twin pregnancy causing fetomaternal haemorrhage and single twin demise: case report. Case Rep Oncol. 2023;16(1):151–156. doi: 10.1159/000529736.
  • Lok C, Frijstein M, van Trommel N. Clinical presentation and diagnosis of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:42–52. doi: 10.1016/j.bpobgyn.2020.12.001.
  • Bracero LA, Davidian M, Cassidy S. Chorioangioma: diffuse angiomatous form. Chorioangioma; 1993 [updated 2023 Jan 30]. Available from: https://sonoworld.com/fetus/page.aspx?id=165
  • Di Massa G, Stabile G, Romano F, et al. CD133 expression in placenta chorioangioma presenting as a giant asymptomatic mass. Medicina. 2021;57(2):162. doi: 10.3390/medicina57020162.
  • Carlucci S, Stabile G, Catagini S, et al. Fetal disseminated intravascular coagulopathy, hydrops and massive umbilical vein thrombosis consequence of a rare placental condition: multifocal chorangiomatosis. J Matern Fetal Neonatal Med. 2022;35(20):4009–4013.
  • Carlucci S, Stabile G, Sorrentino F, et al. The singular case of multiple chorangioma syndrome in an IVF pregnancy. Analysis of the case and review of literature. Placenta. 2021;103:120–123. doi: 10.1016/j.placenta.2020.10.025.
  • Stabile G, Scalia MS, Stampalija T, et al. Placental chorangiocarcinoma a specific histological pattern of uncertain incidence and clinical impact: systematic review of the literature. J Clin Med. 2023;12(9):3065. doi: 10.3390/jcm12093065.
  • Jauniaux E, Zucker M, Meuris S, et al. Chorangiocarcinoma: an unusual tumour of the placenta. The missing link? Placenta. 1988;9(6):607–613. doi: 10.1016/0143-4004(88)90004-5.